Sean F. Moran, Chief Financial Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), sold 36,086 shares at $46.77 ($1.7M) on 2024-06-17, disclosed to the SEC on 2024-06-18.
Scheduled sale ($1.7M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.87 | 1,567 | $78K | 4.5% |
| 2 | $49.87 | 1,567 | $78K | 4.5% |
| 3 | $49.87 | 7,788 | $388K | 22.5% |
| 4 | $49.87 | 7,788 | $388K | 22.5% |
| 5 | $46.77 | 6,730 | $315K | 18.2% |
| 6 | $46.77 | 6,730 |
| $315K |
| 18.2% |
| 7 | $42.12 | 1,958 | $82K | 4.8% |
| 8 | $42.12 | 1,958 | $82K | 4.8% |
| Total | $47.87 avg | 36,086 | $1.7M | 100% |
| Filing → |
| CRBP | SELL | 2025-10-27 | $442K | — | Filing → |
| CRBP | SELL | 2025-02-18 | $24K | — | Filing → |
| CRBP | BUY | 2022-08-10 | $5K | — | Filing → |